Related Experiment Video
Updated: Apr 18, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Unity in diversity: shared mechanism of entry among paramyxoviruses
Jean-Louis Palgen1, Eric M Jurgens2, Anne Moscona3
1Department of Pediatrics, Weill Cornell Medical College, Cornell University, New York, USA; Department of Biology, Ecole Normale Supérieure, Lyon, France.
Abstract:
The Paramyxoviridae family includes many viruses that are pathogenic in humans, including parainfluenza viruses, measles virus, respiratory syncytial virus, and the emerging zoonotic Henipaviruses. No effective treatments are currently available for these viruses, and there is a need for efficient antiviral therapies. Paramyxoviruses enter the target cell by binding to a cell surface receptor and then fusing the viral envelope with the target cell membrane, allowing the release of the viral genome into the cytoplasm. Blockage of these crucial steps prevents infection and disease. Binding and fusion are driven by two virus-encoded glycoproteins, the receptor-binding protein and the fusion protein, that together form the viral "fusion machinery." The development of efficient antiviral drugs requires a deeper understanding of the mechanism of action of the Paramyxoviridae fusion machinery, which is still controversial. Here, we review recent structural and functional data on these proteins and the current understanding of the mechanism of the paramyxovirus cell entry process.
Insights
Paramyxoviruses cause human diseases and need new antiviral treatments. Understanding their cell entry mechanism, involving viral fusion proteins, is key to developing effective therapies.
Area of Science:
- Virology
- Molecular Biology
- Structural Biology
Background:
- Paramyxoviridae viruses, including measles and RSV, cause significant human illness.
- Current treatments for these viral infections are limited, highlighting the need for novel antiviral therapies.
- Paramyxovirus entry into host cells involves viral envelope fusion mediated by viral glycoproteins.
Purpose of the Study:
- To review recent structural and functional data on paramyxovirus fusion machinery.
- To elucidate the mechanism of paramyxovirus cell entry.
- To provide insights for the development of antiviral drugs targeting paramyxovirus fusion.
Main Methods:
- Review of recent structural and functional studies of paramyxovirus glycoproteins.
- Analysis of data on the paramyxovirus cell entry process.
- Synthesis of current understanding regarding the paramyxovirus fusion machinery.
Main Results:
- Paramyxovirus cell entry relies on a fusion machinery composed of receptor-binding and fusion proteins.
- The precise mechanism of action of this fusion machinery remains a subject of ongoing research and debate.
- Recent structural and functional data offer new perspectives on viral entry.
Conclusions:
- A deeper understanding of the paramyxovirus fusion mechanism is critical for antiviral drug development.
- Targeting the viral fusion machinery presents a promising strategy for combating paramyxovirus infections.
- Further research is needed to fully resolve the controversies surrounding the fusion mechanism.
More Related Videos
09:08Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
Published on: July 27, 2021
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
Related Concept Videos
Influenza
Viral Structure
Viral Recombination
Viruses with RNA Genomes
Leaky Scanning
Intracellular Movement of Viruses and Bacteria